Symbol="ZLAB"
AssetType="Common Stock"
Name="Zai Lab Ltd"
Description="Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China."
CIK="1704292"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2359279000"
EBITDA="-385892992"
PERatio="None"
PEGRatio="None"
BookValue="9.63"
DividendPerShare="0"
DividendYield="0"
EPS="-4.32"
RevenuePerShareTTM="2.619"
ProfitMargin="-1.561"
OperatingMarginTTM="-1.568"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.366"
RevenueTTM="251801000"
GrossProfitTTM="-145386000"
DilutedEPSTTM="-4.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.429"
AnalystTargetPrice="72.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.13"
PriceToBookRatio="3.106"
EVToRevenue="12.53"
EVToEBITDA="-4.723"
Beta="1.087"
num_52WeekHigh="53.95"
num_52WeekLow="20.98"
num_50DayMovingAverage="27.89"
num_200DayMovingAverage="33.64"
SharesOutstanding="98389000"
DividendDate="None"
ExDividendDate="None"
symbol="ZLAB"
open="22.71"
high="23.25"
low="22.58"
price="22.72"
volume="250152.00"
latest_trading_day="2023-08-18"
previous_close="23.39"
change="-0.67"
change_percent="-2.8645%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="1"
Volume_recent_avg="543858"
Change_recent_avg="-0.17"
Delta_recent_avg="1.53"
Variance_recent_avg="0.77"
Change_ratio_recent_avg="-0.63"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="170"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_negative_thumbnail_id_2="1150"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0183.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="958"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_positive_thumbnail_id_2="689"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
